Prolonged Exposure to Organophosphates Worsens the Cognitive Outcome of Prediabetes: Possible Modulation by Arachidonic Acid Supplementation

Rowan Arida,Heba-Tallah A. Abd Elkader,Salwa Aborajeh,Mai M. Helmy,Ahmed I. El-Mallah,Salwa M. Abdallah,Ahmed F. El-Yazbi
DOI: https://doi.org/10.1124/jpet.506.966210
2024-05-15
Journal of Pharmacology and Experimental Therapeutics
Abstract:ID 96621 Poster Board 506 Organophosphorus compounds (OPPs) are commonly used as pesticides in agriculture worldwide. Climatic shifts and changes in seasonal patterns led to an increasing use of pesticides with potentially increased chronic exposure, particularly in smallholder growers in low- to middle-income countries self-applying OPPs. Prolonged and repeated exposure to OPPs is associated with neuroinflammatory changes manifesting as memory loss, cognitive impairment, and dementia. This is further compounded by an upsurge in metabolic disorders such as prediabetes, type 2 diabetes, and obesity, also known to confer increased risk of neuroinflammation and cognitive decline. Here, we investigated the possible interplay between chronic OPP exposure and early prediabetes in the development of neuroinflammation and cognitive impairment. Further, owing to the potential impact of OPPs on the endocannabinoid system, we examined whether arachidonic acid supplementation as a precursor of endogenous cannabinoids might modify the cognitive outcome of OPP exposure. Male Sprague-Dawley rats were randomly divided into two groups, a control group fed standard and a prediabetic group receiving high-fat diet (HFD). After 8 weeks, rats from either group were exposed to either DMSO or 40% of LD50 of chlorpyrifos (CPF) by dermal exposure for 35 days. Half of the CPF-exposed rats from either group were treated with Arachidonic Acid (AA) 3 mg/Kg/day by oral gavage for the final 26 days of CPF exposure. Prior to sacrifice, rats were subjected to a battery of behavioral tests to assess their cognitive function. After sacrifice, serum and tissue samples were isolated and stored at -80°C until further examination. Indeed, prediabetic rats showed reduced short-term memory performance in the novel object recognition and Y-maze tests. CPF exposure further diminished the measured parameters. However, arachidonic acid supplementation led to an amelioration of the short-term memory to baseline values in control rats and improved values in prediabetic rats. As such, our current results indicate that OPP exposure further complicates the impaired cognitive phenotype associated with early metabolic disorders. Additionally, this pathological mechanism is amenable to mitigation by arachidonic acid supplementation possibly acting as a precursor of endogenous cannabinoids. Further structural and molecular studies are under way to confirm and elaborate on the proposed pathway. This study is funded by grant# 45912 from the Science, Technology, and Innovation Funding Authority.
pharmacology & pharmacy
What problem does this paper attempt to address?